The present invention provides for methods, compositions, and kits for producing an induced pluripotent stem cell from a non-pluripotent mammalian cell using a 3′-phosphoinositide-dependent kinase-1 (PDK1) activator or a compound that promotes glycolytic metabolism as well as other small molecules.
BALDWIN, JACK E.;ADLINGTON, ROBERT M.;GOLLINS, DAVID W.;SCHOFIELD, CHRIST+, J. CHEM. SOC. CHEM. COMMUN.,(1990) N, C. 720-721
作者:BALDWIN, JACK E.、ADLINGTON, ROBERT M.、GOLLINS, DAVID W.、SCHOFIELD, CHRIST+
DOI:——
日期:——
REPROGRAMMING CELLS
申请人:The Scripps Research Institute
公开号:EP2553086A1
公开(公告)日:2013-02-06
Reprogramming Cells
申请人:The Scripps Research Institute
公开号:US20160257938A1
公开(公告)日:2016-09-08
The present invention provides for methods, compositions, and kits for producing an induced pluripotent stem cell from a non-pluripotent mammalian cell using a 3′-phosphoinositide-dependent kinase-1 (PDK1) activator or a compound that promotes glycolytic metabolism as well as other small molecules.